Enter Note Done
Go to previous page in this tab
Session
  • Presentation | Refining Lipid Management: Biomarkers, Guidelines, and Precision Therapy
  • Population
  • Bookmark Icon
  • Long-Term Efficacy and Safety of Enlicitide in an Open-Label Extension Study
  • Schedule
    Notes
  • MDP2857
    Set Timezone
  •  
    View Map

Generic 'disconnected' Message
Christie Ballantyne, Baylor Coll Med, Houston, TX; Johnathan Parham, Jodi Carrillo, Puja Banka, Merck & Co., Inc., Rahway, NJ; Alberico L Catapano, Univ of Milan; IRCCS Multimedica, Milano, Italy; Dirk Jacobus Blom, Univ of Cape Town, Cape Town, South Africa; Alberto Cadena, Clínica de la Costa, Barranquilla, Colombia; Norman E Lepor, Natl Heart Inst, Beverly Hills, CA; Kazuhisa Tsukamoto, Teikyo Univ Sch of Med, Tokyo, Japan; Julio E Nuez Llota, Univ Hosp of Valencia, Madrid, Spain; Jean-Claude Tardif, Montreal Heart Inst, Univ de Montréal, Montreal, QC, Canada; Emil Andreas Asprusten, Lipid Clinic, Oslo Univ Hosp, Oslo, Norway; Russell SCOTT, NZ Clinical Res, Christchurch, New Zealand; Weiwei He, Merck & Co., Inc., Rahway, PA; Przem Gorski, Laura Gellis, Merck & Co., Inc., Rahway, NJ; Erik S Stroes, Dept of Vascular Med, Amsterdam Cardiovascular Sciences, Amsterdam UMC, Univ of Amsterdam, Amsterdam, Netherlands; Ann Marie Navar, Dept of Med, Div of Cardiology, Univ of Texas Southwestern Medical Ctr, Dallas, TX
Communities
Navigation
Session Type
Onsite Viewing
Main Session